|
John L. Miclot became President and CEO of Respironics, Inc., on December 1, 2003. In November 2002 he was appointed the company’s Chief Strategic Officer responsible for developing and implementing strategic business and growth initiatives, both domestically and internationally, for each of Respironics’ four divisions. In May 2003, he was elected to the Board of Directors. Prior to his position as Chief Strategic Officer he was the President of the Homecare Division from July 1999 to November 2002, where he oversaw strategic direction, sales and marketing, operations as well as research and development for the company’s largest division. Miclot joined Respironics in 1998 when it acquired Healthdyne Technologies where he had served as Senior Vice President, Sales and Marketing from 1995-1998. He was appointed Group Vice President, Sleep Disorders, and was quickly promoted to Senior Vice President, Sales, Marketing and Manufacturing. Miclot began his career in sales for both DeRoyal Industries and the Edward’s Critical Care Division of Baxter Healthcare. Miclot became a Product Manager in 1985 for Baxter’s pulmonary artery catheter product line and moved to Southern California where he assumed positions of increasing responsibility in the marketing and business development areas.In 1988 he joined the Ohmeda Division of BOC Healthcare as Director of Marketing. In this position, he directed research and development investments and developed annual operating plans and global strategic plans. Miclot was appointed Director of International Marketing and Service in 1992 and assumed the position of Vice President of International Marketing in 1993. In 1994, Miclot joined Medex Inc., a medical device company specializing in cardiovascular pressure monitoring, as Vice President of Marketing. Miclot earned a Bachelor of Business Administration degree in Marketing from the University of Iowa. He is currently a member of the Young Presidents Organization.
| 